PCSA stock forecast
Our latest prediction for Processa Pharmaceuticals Inc's stock price was made on the Feb. 12, 2024 when the stock price was at 2.48$.
In the short term (2weeks), PCSA's stock price should underperform the market by -2.93%. During that period the price should oscillate between -76.91% and +68.45%.
In the medium term (3months), PCSA's stock price should underperform the market by -7.90%. During that period the price should oscillate between -194.91% and +169.94%.
Get email alertsCreate a solid portfolio with PCSA
About Processa Pharmaceuticals Inc
processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.17$ per share.
The book value per share is 1.20$
Three months stock forecastFeb. 12, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -22M | - | -21M | -1.17 | - | - | 24M | 1.20 | - | - | - |